3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
4
Prostatic Neoplasms
3
Glioma
3
Glioblastoma
3
Uterine Cervical Dysplasia
2
Sarcoma
2
Breast Neoplasms
2
Atypical Squamous Cells of the Cervix
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Spinal Cord Neoplasms
1
Sexuality
1
Pilonidal Sinus
1
Peritoneal Neoplasms
1
Pelvic Organ Prolapse
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibroma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyoma
1
Interventions
Cyclophosphamide
3
regorafenib
2
Proton Therapy
2
Methods
2
Gemcitabine
2
Doxorubicin
2
tocilizumab
1
poly ICLC
1
pembrolizumab
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
flt3 ligand protein
1
endostar protein
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Transcranial Direct Current Stimulation
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Restraint, Physical
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Platinum
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Restraint, Physical
×
1 year
×
Clear all
NCT05051059
2026-03-16
QOLSarcoma
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
60 enrolled